COMMUNIQUÉS West-GlobeNewswire

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
25/08/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 25 août 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
25/08/2026
PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
25/08/2026
GLEN ALLEN, Va., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new employee stock option [...]
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
25/08/2026
COPENHAGEN, Denmark, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its participation at ISDS 2026, the annual meeting of the International Skeletal Dysplasia Society being [...]
Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072
25/08/2026
Both doses of SPY072 demonstrated statistically significant benefits compared to placebo on one or more of the primary (change from baseline in DAS28-CRP), key secondary (ACR20), and exploratory endpoints (e.g., ACR50) [...]
Acquisition of Own Shares
25/08/2026
Mechelen, Belgium; 25 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Incuvate Files Patent Infringement Lawsuit Against Penumbra
25/08/2026
Complaint alleges Penumbra’s THUNDERBOLT™ system infringes five Incuvate patents covering blood-clot detection technology IRVINE, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Incuvate, LLC today announced that it has filed [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
25/08/2026
COPENHAGEN, Denmark, August 25, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]
BrewDog cumule les distinctions aux World Beer Awards 2026 et confirme l’excellence de son savoir-faire brassicole
25/08/2026
Les bières Hazy Jane, Wingman et Mackie’s Two Scoops remportent une médaille d’or et le titre de meilleure de leur catégorie en Écosse. Les références Punk IPA, Lost Lager, Black Heart et Mello se distinguent également [...]
Rio Tinto Canada Fund invests $2 million to advance healthcare innovation in Quebec
25/08/2026
Support for two groundbreaking initiatives will accelerate innovation, strengthen patient care and advance research with global impact MONTREAL, Aug. 25, 2026 (GLOBE NEWSWIRE) -- The Rio Tinto Canada Fund is investing $ [...]
Le Fonds Rio Tinto Canada investit 2 millions de dollars pour faire avancer l’innovation en santé au Québec
25/08/2026
Le soutien apporté à deux projets novateurs accélérera l’innovation, renforcera les soins aux patients et fera progresser la recherche, à l’échelle mondiale MONTRÉAL, 25 août 2026 (GLOBE NEWSWIRE) -- Le Fonds Rio Tinto [...]
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
25/08/2026
Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, providing a new treatment option in front-line GEA Second FDA [...]
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
25/08/2026
HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE [...]
10X Health Expands its Flagship Genetic Test to Now Analyze 27 Genes, Providing the Most Comprehensive Methylation Panel Available
25/08/2026
The expanded Methylation Genetic Test from 10X Health is available at no additional cost, is paired with a wellness concierge, and provides customized protocols SCOTTSDALE, Ariz., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Today [...]
From Margaritas to Medicine: Construction Advances at Ally Medical ER Liberty Hill
25/08/2026
The more than 8,000-square-foot facility takes shape on State Highway 29 in the former home of a beloved local Tex-Mex restaurant. LIBERTY HILL, Texas, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Liberty Hill families will soon [...]
Investors and Entrepreneurs Agree: AI, Enterprise Demand and Investor Confidence Are Reshaping Pharma Tech, According to New McKesson Ventures Report
25/08/2026
Top healthcare investors and entrepreneurs weigh in on priorities, challenges and the direction of innovation across the pharmaceutical value chain SAN FRANCISCO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pharma technology is [...]
Standard Process Launches GI Soothing Supplement for Dogs and Cats
25/08/2026
New probiotic, postbiotic, and botanical formula provides comprehensive gastrointestinal support during periods of digestive upset or distress A Media Snippet accompanying this announcement is available by clicking on [...]
23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
25/08/2026
Reddick, a 13-time NASCAR Cup Series winner and 2026 Daytona 500 Champion, shares how prioritizing sleep health is an important part of his recovery and performance routine SAN DIEGO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- [...]
Genmab to Participate in Upcoming Investor Conferences
25/08/2026
Media Release COPENHAGEN, Denmark; August 25, 2026 Genmab A/S (Nasdaq: GMAB ) announced today that members of its E xecutive Committee will participat e in fireside chats at the following investor conferences in [...]

Pages